BIA-ALCL

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare and highly treatable type of lymphoma that can develop around breast implants. BIA-ALCL occurs most frequently in patients who have breast implants with textured surfaces. According to the most recent data available, the lifetime risk of association between breast implants and ALCL is 1 in 30,000 patients with textured implants in the United States. Some other countries have reported risks between 1 in 1000 to one in 30,000. Since the initial case report in 1996, ASPS now recognizes approximately 194 cases in the US and a total of 518 worldwide as of March 2018 (www.plasticsurgery.org).

To learn more please access:

https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources

https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm